RT Journal Article
SR Electronic
T1 Ziprasidone therapy for post-traumatic stress disorder
JF Journal of Psychiatry and Neuroscience
JO JPN
FD Canadian Medical Association
SP 430
OP 431
VO 30
IS 6
A1 Zakaria Siddiqui
A1 William A. Marcil
A1 Subhash C. Bhatia
A1 Sriram Ramaswamy
A1 Frederick Petty
YR 2005
UL http://jpn.ca/content/30/6/430.abstract
AB We describe the cases of 2 men with chronic combat-induced post-traumatic stress disorder (PTSD) who benefited from therapy with ziprasidone. They did not have active psychotic symptoms. Both the patients had a history of inadequate response to previous trials of different psychotropic agents. Ziprasidone was considered because of its broad-spectrum actions on various neurotransmitters. To our knowledge, this is the first published report of the usefulness of ziprasidone in the pharmacotherapy of PTSD, although atypical antipsychotic agents (e.g., olanzapine, quetiapine and risperidone) have been reported to be beneficial in the treatment of this condition.